Showing results (181-190 of 262) with videos related to

Sort By:
Pageof 27
Histopathology|November 9, 2020
Cytokeratin expression in plasmablastic lymphoma - a possible diagnostic pitfall in the routine work-up of tumoursKatrin S Huettl, Annette M Staiger, Heike Horn, et al.
Blood Neoplasia|January 9, 2026
Impact of European LeukemiaNet-guided postremission therapy on outcomes of patients with AML from 2010 to 2022Andrew F Berdel, Julian Ronnacker, Daniela V Wenge, et al.
Cancers|February 15, 2022
Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic LeukemiaDaniela V Wenge, Klaus Wethmar, Corinna A Klar, et al.
Blood|July 23, 2013
IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCLHendrik Nogai, Sören-Sebastian Wenzel, Stephan Hailfinger, et al.
Blood|December 14, 2004
Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL NetworkMartin Dreyling, Georg Lenz, Eva Hoster, et al.
Hemasphere|January 26, 2023
Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell TherapyConrad-Amadeus Voltin, Philipp Gödel, Laura Beckmann, et al.
Cancers|November 26, 2022
Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World ScenarioCarolin Krekeler, Lea Reitnauer, Ulrike Bacher, et al.
Blood Advances|January 30, 2023
Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysisCatherine Thieblemont, Bettina Altmann, Fabian Frontzek, et al.
The Lancet. Haematology|March 5, 2021
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trialFabian Frontzek, Marita Ziepert, Maike Nickelsen, et al.
Genome Medicine|September 24, 2022
Intratumor heterogeneity and T cell exhaustion in primary CNS lymphomaMichael Heming, Svea Haessner, Jolien Wolbert, et al.
Pageof 27